These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32931563)

  • 41. Tergitol-15-S-9 inactivates SARS-CoV-2 and boosts immunoassay signals.
    Berg MG; Israeli E; Quaco E; Cloherty GA; Hemken PM
    Biotechniques; 2021 Jul; 71(1):370-375. PubMed ID: 34139879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Correlates of protection from SARS-CoV-2 infection.
    Krammer F
    Lancet; 2021 Apr; 397(10283):1421-1423. PubMed ID: 33844964
    [No Abstract]   [Full Text] [Related]  

  • 43. Subunit Nanovaccine with Potent Cellular and Mucosal Immunity for COVID-19.
    Liu L; Liu Z; Chen H; Liu H; Gao Q; Cong F; Gao G; Chen Y
    ACS Appl Bio Mater; 2020 Sep; 3(9):5633-5638. PubMed ID: 35021794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Gupta D; Parthasarathy H; Sah V; Tandel D; Vedagiri D; Reddy S; Harshan KH
    Virus Res; 2021 Nov; 305():198555. PubMed ID: 34487766
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors.
    Juskewitch JE; Senefeld JW; Johnson PW; Mills JR; Joyner MJ; Gandhi MJ
    Mayo Clin Proc; 2021 Oct; 96(10):2727-2728. PubMed ID: 34607639
    [No Abstract]   [Full Text] [Related]  

  • 46. Correlative multi-scale cryo-imaging unveils SARS-CoV-2 assembly and egress.
    Mendonça L; Howe A; Gilchrist JB; Sheng Y; Sun D; Knight ML; Zanetti-Domingues LC; Bateman B; Krebs AS; Chen L; Radecke J; Li VD; Ni T; Kounatidis I; Koronfel MA; Szynkiewicz M; Harkiolaki M; Martin-Fernandez ML; James W; Zhang P
    Nat Commun; 2021 Jul; 12(1):4629. PubMed ID: 34330917
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CAR Macrophages for SARS-CoV-2 Immunotherapy.
    Fu W; Lei C; Ma Z; Qian K; Li T; Zhao J; Hu S
    Front Immunol; 2021; 12():669103. PubMed ID: 34367135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid quantitative detection system for measles virus-neutralizing antibodies using HiBiT-tagged virus-like particles.
    Okura T; Miyakawa K; Tahara M; Someya K; Seki F; Nishi M; Otsuki N; Ryo A
    Microbiol Immunol; 2024 Apr; 68(4):160-164. PubMed ID: 38414102
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neutralizing antibodies for the treatment of COVID-19.
    Jiang S; Zhang X; Yang Y; Hotez PJ; Du L
    Nat Biomed Eng; 2020 Dec; 4(12):1134-1139. PubMed ID: 33293725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. I do not want my baby screened for COVID-19.
    Kelly D; Dal N; Thakker P
    Arch Dis Child; 2021 Sep; 106(9):e36. PubMed ID: 33653711
    [No Abstract]   [Full Text] [Related]  

  • 51. Achieving and sustaining herd immunity to SARS-CoV-2.
    Bolotin S; Wilson S; Murti M
    CMAJ; 2021 Jul; 193(28):E1089. PubMed ID: 34281966
    [No Abstract]   [Full Text] [Related]  

  • 52. Poliovirus neutralization test with poliovirus pseudovirus to measure neutralizing antibody in humans.
    Arya SC; Agarwal N
    Clin Vaccine Immunol; 2012 Mar; 19(3):458; author reply 459. PubMed ID: 22371252
    [No Abstract]   [Full Text] [Related]  

  • 53. A systemic and molecular study of subcellular localization of SARS-CoV-2 proteins.
    Zhang J; Cruz-Cosme R; Zhuang MW; Liu D; Liu Y; Teng S; Wang PH; Tang Q
    Signal Transduct Target Ther; 2020 Nov; 5(1):269. PubMed ID: 33203855
    [No Abstract]   [Full Text] [Related]  

  • 54. Atomic force microscopy analysis of native infectious and inactivated SARS-CoV-2 virions.
    Lyonnais S; Hénaut M; Neyret A; Merida P; Cazevieille C; Gros N; Chable-Bessia C; Muriaux D
    Sci Rep; 2021 Jun; 11(1):11885. PubMed ID: 34088957
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Using proteins to test for COVID antibodies.
    Santoro H
    Nature; 2022 Oct; 610(7930):S3. PubMed ID: 36198786
    [No Abstract]   [Full Text] [Related]  

  • 56. COVID-19 in a Face Transplant Patient.
    Panayi AC; Kauke M; Pomahac B
    Transplantation; 2021 Sep; 105(9):e96-e98. PubMed ID: 33901110
    [No Abstract]   [Full Text] [Related]  

  • 57. Highly sensitive and quantitative HiBiT-tagged Nipah virus-like particles: A platform for rapid antibody neutralization studies.
    Rajan A; Nair AS; Pillai VS; Kumar B; Pai AR; Benny B; Veettil MV
    Heliyon; 2024 Jun; 10(11):e31905. PubMed ID: 38868026
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of HiBiT-Tagged Recombinant Infectious Bronchitis Coronavirus for Efficient
    Liang XY; Zhu QC; Liang JQ; Liu SY; Liu DX; Fung TS
    Front Microbiol; 2020; 11():2100. PubMed ID: 32983065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zika virus protease induces caspase-independent pyroptotic cell death by directly cleaving gasdermin D.
    Yamaoka Y; Matsunaga S; Jeremiah SS; Nishi M; Miyakawa K; Morita T; Khatun H; Shimizu H; Okabe N; Kimura H; Hasegawa H; Ryo A
    Biochem Biophys Res Commun; 2021 Jan; 534():666-671. PubMed ID: 33208231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.
    Abu-Raddad LJ; Chemaitelly H; Butt AA;
    N Engl J Med; 2021 Jul; 385(2):187-189. PubMed ID: 33951357
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.